Amy W Schulman
CIK 1438226 · Former Exec. Vice President · last filed 2026-05-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CAMP price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
235 EAST 42ND STREET
NEW YORK, NY 10017
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALNY | Director | 24,049 | $225.10 | $5.41M | -$5.26M | 20 | 2026-05-22 |
| ELV | Director | 781 | $434.13 | $339.1K | -$7.5K | 3 | 2026-05-15 |
| GUTS | Director | 712 | $1.15 | $819 | $10.0K | 3 | 2025-06-13 |
| CAMP | 10%+ Owner | 112,193 | $3.29 | $369.1K | $60.00M | 1 | 2024-10-15 |
| SQZ Biotechnologies Co (SQZ) Delisted | Director | 216,664 | $0.43 | $94.2K | $4.04M | 7 | 2023-06-15 |
| Hudson Executive Investment Corp. II (HCIIW) Delisted | Director | — | $0.00 | — | $0 | 1 | 2021-04-14 |
| Cyclerion Therapeutics, Inc. (CYCN) Delisted | Director | 209 | $23.52 | $4.9K | $10.02M | 4 | 2020-06-18 |
| IRWD | Director | 38,242 | $3.55 | $135.8K | $0 | 7 | 2019-04-03 |
| IRONWOOD PHARMACEUTICALS INC (IRWDV) Delisted | Director | 42,298 | — | — | $0 | 1 | 2019-03-19 |
| X4 Pharmaceuticals, Inc (ASNS) Delisted | Director | — | $0.08 | — | $0 | 3 | 2018-06-07 |
| BUFF | Director | 0 | $54.35 | $0 | $0 | 3 | 2018-04-24 |
| DNIB UNWIND, INC. (BIND) Delisted | Director | — | — | — | $0 | 2 | 2015-06-10 |
| PFE | Former Exec. Vice President | 280,380 | $29.85 | $8.37M | -$4.61M | 50 | 2014-01-02 |
| ZTS | Director | 5,000 | $79.62 | $398.1K | $130.0K | 1 | 2013-02-08 |
Recent Filings · Page 7 of 11
108 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-11-18 | PFE | Grant (A) | — | $0 | EDGAR |
| 2013-11-04 | PFE | Grant (A) | — | $0 | EDGAR |
| 2013-10-16 | PFE | Grant (A) | — | $0 | EDGAR |
| 2013-10-02 | PFE | Grant (A) | — | $0 | EDGAR |
| 2013-09-17 | PFE | Grant (A) | — | $0 | EDGAR |
| 2013-09-04 | PFE | Grant (A) | — | $0 | EDGAR |
| 2013-08-16 | PFE | Grant (A) | — | $0 | EDGAR |
| 2013-08-01 | PFE | Grant (A) | — | $0 | EDGAR |
| 2013-07-16 | PFE | Grant (A) | — | $0 | EDGAR |
| 2013-07-02 | PFE | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.